Search results for

Gilead Sciences is donating its initial supply of the experimental treatment for COVID-19. The federal government is deciding where the scarce medicine goes, and there are questions about the choices.

A Senate panel is looking to see if the company is keeping conservative media and bloggers out of top search results. Google has previously denied political bias.

With the death toll nearing 200 and thousands more civilians left homeless, the United Nations is pushing for a cease-fire.

NPR's Sarah McCammon speaks to pharmacist Drew Massey about West Virginia's successful vaccination drive and the lessons other states can take away from the effort.

The Dow tumbled more than 900 points as COVID-19 cases surge in the United States and Europe, while next week's election is only adding to the uncertainty over the economy.

The defense team played its own videos before the Senate, attempting to show that the former president did not incite the insurrection at the U.S. Capitol.

For most people, more education leads to healthier and longer lives. Not so for Black men. Racism's power in harming their health may be more persistent than previously understood, researchers say.

The global shortage of chips could hurt production of iPads and Macs, costing Apple $3 billion to $4 billion in revenue, in what is the latest example of a company being hit by supply constraints.

In recent years, there has been an emphasis on ornamental landscape plants that provide bee and butterfly habitat. But did you know that you can also…

When businesses have accused Google of antitrust violations in the past, they've often focused on its key asset: search. We look at the complaints, and Google's response.